Does ELTROMBOPAG Cause Myelofibrosis? 89 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 89 reports of Myelofibrosis have been filed in association with ELTROMBOPAG. This represents 1.6% of all adverse event reports for ELTROMBOPAG.
89
Reports of Myelofibrosis with ELTROMBOPAG
1.6%
of all ELTROMBOPAG reports
11
Deaths
17
Hospitalizations
How Dangerous Is Myelofibrosis From ELTROMBOPAG?
Of the 89 reports, 11 (12.4%) resulted in death, 17 (19.1%) required hospitalization, and 3 (3.4%) were considered life-threatening.
Is Myelofibrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELTROMBOPAG. However, 89 reports have been filed with the FAERS database.
What Other Side Effects Does ELTROMBOPAG Cause?
Platelet count decreased (968)
Death (629)
Drug ineffective (554)
Product use in unapproved indication (303)
Thrombocytopenia (262)
Off label use (255)
Headache (229)
Pyrexia (229)
Haemoglobin decreased (213)
Pneumonia (204)
What Other Drugs Cause Myelofibrosis?
RUXOLITINIB (1,316)
ROMIPLOSTIM (89)
HYDROXYUREA (88)
IMATINIB (76)
DEFERASIROX (57)
MOMELOTINIB (51)
ASPIRIN (46)
RITUXIMAB (43)
ANAGRELIDE (41)
ELTROMBOPAG OLAMINE (39)
Which ELTROMBOPAG Alternatives Have Lower Myelofibrosis Risk?
ELTROMBOPAG vs ELTROMBOPAG OLAMINE
ELTROMBOPAG vs ELUXADOLINE
ELTROMBOPAG vs ELVITEGRAVIR
ELTROMBOPAG vs EMAPALUMAB
ELTROMBOPAG vs EMAPALUMAB-LZSG